Promotion of Joint Degeneration and Chondrocyte Metabolic Dysfunction by Excessive Growth Hormone in Mice
暂无分享,去创建一个
M. Lotz | Huanhuan Liu | Luke Witzigreuter | Shouan Zhu | J. Kopchick | D. Berryman | R. Basu | Stephen Bell | Patrick O'Connor | C. Willis | Trent Davis | Nathaniel J. Szewczyk | Marcheta Hill | Roberto J. Fajardo
[1] T. Griffin,et al. Sirt3 Promotes Chondrogenesis, Chondrocyte Mitochondrial Respiration and the Development of High‐Fat Diet‐Induced Osteoarthritis in Mice , 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] Jing Li,et al. Analysis of Serum Metabolomics in Rats with Osteoarthritis by Mass Spectrometry , 2021, Molecules.
[3] R. Kineman,et al. Sexual dimorphic impact of adult‐onset somatopause on life span and age‐induced osteoarthritis , 2021, Aging cell.
[4] P. Clegg,et al. Ex-Vivo Equine Cartilage Explant Osteoarthritis Model - A Metabolomics and Proteomics Study , 2020, bioRxiv.
[5] R. Loeser,et al. Naturally occurring osteoarthritis in male mice with an extended lifespan , 2020, Connective tissue research.
[6] H. Baelde,et al. Protective Actions of Anserine Under Diabetic Conditions , 2018, International journal of molecular sciences.
[7] T. Griffin,et al. Independent effects of dietary fat and sucrose content on chondrocyte metabolism and osteoarthritis pathology in mice , 2018, Disease Models & Mechanisms.
[8] C. Pineda,et al. Hyperlipidemic microenvironment conditionates damage mechanisms in human chondrocytes by oxidative stress , 2017, Lipids in Health and Disease.
[9] A. Mobasheri,et al. The role of metabolism in the pathogenesis of osteoarthritis , 2017, Nature Reviews Rheumatology.
[10] Elizabeth A. Jensen,et al. Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles. , 2014, Endocrinology.
[11] J. Kopchick,et al. The GH/IGF-1 axis in ageing and longevity , 2013, Nature Reviews Endocrinology.
[12] M. Takigawa,et al. Impaired glycolytic metabolism causes chondrocyte hypertrophy-like changes via promotion of phospho-Smad1/5/8 translocation into nucleus. , 2013, Osteoarthritis and cartilage.
[13] M. Farias,et al. Functional evaluation of the joints in acromegalic patients and associated factors , 2013, Clinical Rheumatology.
[14] D. Leroith,et al. The Intricate Role of Growth Hormone in Metabolism , 2011, Front. Endocrin..
[15] Federica Madia,et al. Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans , 2011, Science Translational Medicine.
[16] C. Little,et al. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. , 2010, Osteoarthritis and cartilage.
[17] I. Robinson,et al. Regulation of rapid signal transducer and activator of transcription-5 phosphorylation in the resting cells of the growth plate and in the liver by growth hormone and feeding. , 2009, Endocrinology.
[18] J. Frystyk,et al. Impact of fasting on growth hormone signaling and action in muscle and fat. , 2009, The Journal of clinical endocrinology and metabolism.
[19] H. Doll,et al. Impact of musculoskeletal disease on quality of life in long-standing acromegaly. , 2008, European journal of endocrinology.
[20] Steven A Olson,et al. Joint degeneration following closed intraarticular fracture in the mouse knee: A model of posttraumatic arthritis , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[21] M. Jensen,et al. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. , 2007, American journal of physiology. Endocrinology and metabolism.
[22] B. Lindgren,et al. Effects of chronic growth hormone and insulin-like growth factor 1 deficiency on osteoarthritis severity in rat knee joints. , 2006, Arthritis and rheumatism.
[23] C. Gravholt,et al. Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans. , 2004, American journal of physiology. Endocrinology and metabolism.
[24] A. Bartke. Can Growth Hormone (GH) Accelerate Aging? Evidence from GH-Transgenic Mice , 2003, Neuroendocrinology.
[25] Amy N Holland,et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. , 2003, Endocrinology.
[26] M. Wilson. Insulin-like growth factor I (IGF-I) replacement during growth hormone receptor antagonism normalizes serum IGF-binding protein-3 and markers of bone formation in ovariectomized rhesus monkeys. , 2000, The Journal of clinical endocrinology and metabolism.
[27] J. Bülow,et al. Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. , 1999, American journal of physiology. Endocrinology and metabolism.
[28] K. Sjögren,et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Straume,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Growth Hormone (GH) Receptor Blockade with a PEG- Modified GH (B2036-PEG) Lowers Serum Insulin-Like Growth Factor-I but Does Not Acutely Stimula , 1998 .
[30] J. Miles,et al. Effects of pulsatile delivery of basal growth hormone on lipolysis in humans. , 1996, The American journal of physiology.
[31] Ross,et al. The Human Growth Hormone (hGH) Antagonist G1zoRhGH Does Not Antagonize GH in the Rat, But Has Paradoxical Agonist Activity, Probably Via the Prolactin Receptor* , 2001 .
[32] A. Nahir,et al. Differential decline of rabbit chondrocytic dehydrogenases with age. , 1995, International journal of experimental pathology.
[33] G. Werther,et al. Identification of growth hormone receptors on human growth plate chondrocytes , 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[34] B. Bengtsson,et al. The prevalence of radiographic osteoarthritis is low in elderly patients with growth hormone deficiency. , 1993, Acta endocrinologica.
[35] M. Waters,et al. Localization of the growth hormone receptor, identified by immunocytochemistry, in second trimester human fetal tissues and in placenta throughout gestation. , 1992, The Journal of clinical endocrinology and metabolism.
[36] T. Wagner,et al. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. , 1991, Endocrinology.
[37] T. Wagner,et al. Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[38] G. Herrero-Beaumont,et al. Differences between radiographic abnormalities of acromegalic arthropathy and those of osteoarthritis. , 1990, Arthritis and rheumatism.
[39] A. Barkan,et al. Acromegalic arthropathy. Characteristics and response to therapy. , 1988, Arthritis and rheumatism.
[40] T. Shimamura,et al. Alteration of tryptophan metabolism in the synovial fluid of patients with rheumatoid arthritis and osteoarthritis. , 1987, The Tohoku journal of experimental medicine.
[41] J. Jansson,et al. Growth hormone stimulates longitudinal bone growth directly. , 1982, Science.
[42] J. A. Scarlett,et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. , 2000, The New England journal of medicine.
[43] A. Oberbauer,et al. Growth hormone and IGF-I stimulate cell function in distinct zones of the rat epiphyseal growth plate. , 1995, Connective tissue research.
[44] E. Martino,et al. [Acromegalic arthropathy]. , 1993, La Clinica terapeutica.
[45] R. Silberberg. Articular aging and osteoarthrosis in dwarf mice. , 1972, Pathologia et microbiologia.